Financials data is unavailable for this security.
View more
Year on year Bioxyne Ltd had net income fall 559.75% from a loss of 1.94m to a larger loss of 12.80m despite a 80.70% increase in revenues from 5.16m to 9.33m. An increase in the cost of goods sold as a percentage of sales from 63.21% to 63.56% was a component in the falling net income despite rising revenues.
Gross margin | 36.44% |
---|---|
Net profit margin | -139.14% |
Operating margin | -142.27% |
Return on assets | -106.39% |
---|---|
Return on equity | -136.57% |
Return on investment | -134.91% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Bioxyne Ltd fell by 2.82m. Cash Flow from Financing totalled 1.24m or 13.34% of revenues. In addition the company used 3.59m for operations while cash used for investing totalled 492.66k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0018 |
---|---|
Tangible book value per share | 0.0016 |
More ▼
Balance sheet in AUDView more
Current ratio | 1.92 |
---|---|
Quick ratio | 1.18 |
Total debt/total equity | 0.0508 |
---|---|
Total debt/total capital | 0.0526 |
More ▼